Stocks making the biggest moves midday: Oracle, Boeing, CureVac, Datadog and more

Several companies experienced significant stock movements in midday trading: Cardinal Health rose 3% to a new high after raising its full-year earnings guidance to $8.15-$8.20 per share, while Oracle surged nearly 14% following strong cloud infrastructure revenue forecasts and better-than-expected Q4 adjusted earnings of $1.70 per share on $15.9 billion in revenue. Conversely, Boeing declined almost 5% after an Air India Boeing Dreamliner crash, and GameStop plummeted 20% after announcing a $1.75 billion convertible senior notes offering.

Analysis

Midday trading showcased significant divergence across sectors, driven by company-specific catalysts. Cardinal Health (CAH) achieved a new all-time high, rising 3% after elevating its full-year adjusted earnings per share guidance to $8.15-$8.20, indicating strong operational momentum and positive investor sentiment (sentiment score: 0.7). Oracle (ORCL) experienced a substantial surge of nearly 14%, fueled by fiscal fourth-quarter adjusted earnings of $1.70 per share and revenue of $15.9 billion, both surpassing analyst expectations, and a highly optimistic forecast from CEO Safra Catz for over 70% cloud infrastructure revenue growth in fiscal year 2026, reflected in a very positive sentiment score of 0.9. Conversely, Boeing (BA) shares declined almost 5% (sentiment score: -0.8) following the first-ever crash of a Dreamliner, an 11-year-old Air India plane, raising immediate safety and operational concerns; this negativity also impacted other airline stocks like United Airlines (UAL) and Delta Air Lines (DAL), which fell over 3% and 2% respectively. GameStop (GME) plummeted 20% (sentiment score: -0.8) upon announcing a $1.75 billion convertible senior notes offering, signaling potential shareholder dilution and uncertainty over the use of proceeds for 'general corporate purposes, including making investments.' In the biotech M&A space, CureVac (CVAC) shares jumped 38% (sentiment score: 0.9) following BioNTech's (BNTX) agreement to acquire it in a $1.25 billion all-stock deal. Technology sentiment was also buoyed by Datadog (DDOG), which advanced over 3% (sentiment score: 0.6) on an upgrade to outperform from Wolfe Research, citing AI-driven growth prospects. The IPO market showed activity with Voyager Technologies rising 4% after an 82% surge on its first trading day above its $31 IPO price, and Chime Financial pricing its IPO at $27 per share, valuing the company at $11.6 billion ahead of its trading debut.

Key Decisions for Investors

• Investors should closely monitor the investigation into the Boeing Dreamliner incident, as findings could have prolonged adverse effects on BA's stock and potentially the wider aerospace sector.
• While Oracle's strong earnings and aggressive cloud growth guidance are positive, it is prudent to evaluate the long-term sustainability and execution risks associated with such ambitious targets.
• For GameStop, the significant capital raise via convertible notes warrants a careful assessment of potential shareholder dilution and scrutiny of the company's forthcoming investment strategy.
• CureVac shareholders have seen a significant premium realized from the BioNTech acquisition; BioNTech investors, conversely, should assess the strategic rationale and integration risks of this all-stock deal.
• Given the typical volatility of newly public companies, approach recent IPOs like Voyager Technologies and the upcoming Chime Financial listing with caution, prioritizing fundamental analysis over initial trading momentum.